Medicare Audit Uncovers $400 Million in Unused Organ Expenses

Audit Revelation

A federal oversight examination has revealed that Medicare paid between $380 million and $400 million over six years for organs not used in transplants covered by Medicare. This discovery raises concerns regarding the reimbursement practices of transplant centers, as well as potential discrepancies between federal guidance and statutory requirements.

The Department of Health and Human Services Office of Inspector General (OIG) conducted the audit, uncovering inconsistencies between federal law and guidance issued by the Centers for Medicare & Medicaid Services (CMS). The audit highlighted payments made to transplant centers for organs transplanted into non-Medicare patients or not transplanted at all.

Why It Matters

These findings emerge during heightened scrutiny of federal health-care expenditures and Medicare’s financial sustainability. Organ transplantation stands out as one of Medicare’s priciest services, with transplant center reimbursements exceeding $3 billion for 39,000 organs in 2023.

The audit suggests current practices might not align with federal law, potentially costing taxpayers hundreds of millions. According to federal law, Medicare may reimburse transplant centers only for organs used in Medicare-covered transplants. However, CMS guidance instructs centers to regard transferred organs as ‘Medicare usable’ based on expectations of future use in Medicare procedures.

Michael Ryan, a finance expert, emphasized the flaw in aligning CMS guidance with federal statutes, noting that taxpayers bear the financial repercussions. Drew Powers, a finance group founder, points out that, spread over six years, the $380 million waste represents only a 2 percent deviation, which seems relatively efficient given the complexity of organ transplants.

Audit Findings

Inspectors scrutinized 180 organs labeled as Medicare-usable from 12 centers, revealing approximately $2.8 million paid for 55 organs not qualifying under federal rules. Of these, 43 were transplanted into non-Medicare patients and 12 were not transplanted. The audit estimates $380 million spent on unsupported transplants over six years.

Root Cause

Federal law permits expenses only for Medicare-utilized organs. Yet, CMS assumes organs distributed to other centers will eventually benefit Medicare recipients. This assumption does not consistently hold, leading to Medicare sharing costs for certain organs that do not serve Medicare beneficiaries.

Steps Forward

OIG recommends CMS directs contractors to retrieve $154,210 from two centers with inadequate documentation for certain claims. Additionally, CMS is urged to modify guidance, counting only organs transplanted into Medicare recipients as Medicare-usable.